Among them, PD1 inhibitor nivolumab (trade name Opdivo) used to treat a variety of cancers, including melanoma, NSCLC, renal cell carcinoma, and head and neck cancer.209, 210, 211, 212. This evidence concerns the gene PDCD1 and non-small cell lung carcinoma.